# A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

> **NCT02423239** · PHASE1 · UNKNOWN · sponsor: **e-Therapeutics PLC** · enrollment: 112 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Pancreatic Cancer

## Interventions

- **DRUG:** Dexanabinol
- **DRUG:** Sorafenib
- **DRUG:** Nab-paclitaxel
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT02423239
- **Lead sponsor:** e-Therapeutics PLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2016-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02423239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02423239, "A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02423239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*